The New York Times: Moderna Sues Pfizer and BioNTech Over Covid Vaccine.
>"The lawsuit, filed Friday, alleges that the companies’ Covid vaccine violated _...Read More_
The New York Times: Moderna Sues Pfizer and BioNTech Over Covid Vaccine.
>"The lawsuit, filed Friday, alleges that the companies’ Covid vaccine violated _...Read More_
CNBC: Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots.
>"Moderna took a nearly $500 million hit on write-downs for vaccine _...Read More_
CNBC: Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots.
>"Moderna took a nearly $500 million hit on write-downs for vaccine _...Read More_
CNBC: CDC panel unanimously recommends Novavax Covid-19 vaccine for adults.
>"Novavax uses different technology than Pfizer and Moderna. U.S. _...Read More_
CNBC: CDC panel unanimously recommends Novavax Covid-19 vaccine for adults.
>"Novavax uses different technology than Pfizer and Moderna. U.S. _...Read More_
"The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months."
"The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months."
"A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work."
"A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work."
"Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. "
"Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. "
"The European Medicines Agency’s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation from women who had received Covid-19 vaccines from Pfizer/BioNTech and Moderna."
"The European Medicines Agency’s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation from women who had received Covid-19 vaccines from Pfizer/BioNTech and Moderna."
>"The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data."
>"The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data."